Skip to main content

ESCALON MEDICAL CORP

corporate_fare Company Profile

ESCALON MEDICAL CORP

ESMC·OTC·Healthcare·CIK 0000862668

Escalon Medical Corp. is a Pennsylvania corporation, reincorporated in November 2001, that operates in the healthcare market. The Company, which includes its division Trek and wholly owned subsidiaries Sonomed, Inc., Escalon Digital Solutions, Inc., and Sonomed IP Holdings, Inc., specializes in the development, manufacture, marketing, and distribution of medical devices for ophthalmic applications. Its products are subject to regulation and inspection by the United States Food and Drug Administration (FDA). Escalon's product offerings include A-Scans, B-Scans, and UBM devices. A-Scans provide information about the internal structure of the eye using ultrasound to display echoes from surfaces like the cornea, lens, and retina, and include software for measuring distances within the eye, primarily for calculating lens power for implants. B-Scans are diagnostic tools that use an ultrasound beam to image internal eye structures when the eye's media are cloudy or opaque, providing a two-dimensional image by swinging the transducer through a 60-degree sector. UBM devices are high frequency/high resolution ultrasound devices designed to provide detailed information about the anterior segment of the eye.

ESCALON MEDICAL CORP (OTC:ESMC) is a publicly traded company in the Healthcare sector. Wiseek monitors ESMC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Asset Sale Boosts Cash, But Going Concern Warning Persists Amid Revenue Decline
  • Going Concern Warning Amidst Losses, Offset by $3M Asset Sale and Material Control Weakness
  • Escalon Medical Completes $3M AXIS Platform Sale, Receives $1M Initial Payment

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$12.05M
Net Income
$105.53K
Diluted EPS
$0.00
Op. Cash Flow
$380.73K
Free Cash Flow
$376.85K
Gross Profit
$5.51M
Operating Income
$133.22K
Cash & Equivalents
$545.84K
Debt / Equity
0.00×
Net Margin
0.9%
Shares Outstanding
7.42M sh
Source: 10-K · filed 2025-09-29 · accession 0001628280-25-043095
Browse all tickers starting with E →
$0.1983
52-week range · as of 2026-05-15 $0.1001 – $0.4625
Market cap
$1.47M
Volume
6.3K (0.2× avg)
3-mo avg 37.5K
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ESMC - Latest Insights

ESMC
May 15, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2507
Real-time Price: $0.1983 info
Change: -$0.0524 (-21%) info
Market Cap: $1.47M info
ESMC
Feb 17, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $0.1983 info
Change: +$0.0261 (+15%) info
Market Cap: $1.47M info
ESMC
Jan 29, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.160
Real-time Price: $0.1983 info
Change: +$0.0383 (+24%) info
Market Cap: $1.47M info